Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

1. Jerusalem, G.
2. Mariani, G.
3. Ciruelos, E.M.
4. Martin, M.
5. Tjan-Heijnen, V.C.G.
6. Neven, P.
7. Gavila, J.G.
8. Michelotti, A.
9. Montemurro, F.
10. Generali, D.
11. Simoncini, E.
12. Lang, I.
13. Mardiak, J.
14. Naume, B.
15. Camozzi, M.
16. Lorizzo, K.
17. Bianchetti, S.
18. Conte, P.